BRIAN FRIEL
Allopathic & Osteopathic Physicians|Urology PHILADELPHIA, PA NPI 1013440312
Browse related groups: Allopathic & Osteopathic Physicians|Urology PA Axonics Modulation Technologies, Inc. All categories
General Payments — all program years on this page
$4,475.57
- Category: General Payments
- Program years: PY2021–2024
- Record count: 154
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,856.33 across 61 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,788.33 | 60 |
| Education | $68.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Axonics Modulation Technologies, Inc. | $287.94 | 5 |
| Dendreon Pharmaceuticals LLC | $215.68 | 2 |
| ABBVIE INC. | $192.68 | 10 |
| Janssen Biotech, Inc. | $190.75 | 8 |
| Astellas Pharma US Inc | $161.24 | 5 |
| PROCEPT BioRobotics Corporation | $128.66 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $85.61 | 3 |
| TOLMAR, INC. | $82.97 | 4 |
| Medtronic, Inc. | $80.91 | 2 |
| UROGEN PHARMA, INC. | $50.03 | 2 |
| Telix Pharmaceuticals | $45.77 | 2 |
| Sumitomo Pharma America, Inc. | $43.67 | 2 |
| Merck Sharp & Dohme Corporation | $39.35 | 2 |
| BIOPROTECT MEDICAL, INC. | $36.06 | 2 |
| Ferring Pharmaceuticals Inc. | $35.18 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $32.69 | 1 |
| 180 Medical, Inc. | $30.52 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $25.85 | 1 |
| Myriad Genetic Laboratories, Inc. | $21.19 | 1 |
| Acerta Pharma LLC | $19.99 | 1 |
| IMMUNITYBIO, INC. | $17.44 | 1 |
| PFIZER INC. | $16.36 | 1 |
| MISSION PHARMACAL COMPANY | $15.79 | 1 |
By program year
Records — PY2024 (61)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.